Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2009

View Archived Issues

Novel mutilin derivatives with antibacterial activity reported in recent Kyorin patent

Mpex Pharmaceuticals patent discloses novel bacterial efflux pump inhibitors

New angiotensin II AT1 receptor antagonists developed by Eldrug researchers

GSK and Archemix form strategic alliance to develop aptamers for inflammatory diseases

VIA licenses drug candidates from Roche for metabolic disease

GenVec reports on developments in malaria vaccine program

Clinical data on pralatrexate in lymphomas presented at ASH annual meeting

Phase II studies assess single-agent dasatinib in breast cancer

FDA advises NMRC not to initiate clinical trial of Biopure's Hemopure

IGF-1 does not affect outcome measures in phase III amyotrophic lateral sclerosis trial

Vinflunine with trastuzumab active as first-line treatment in metastatic breast cancer

Acura and King Pharmaceuticals submit NDA to FDA for Acurox anti-abuse opioid analgesic

EMEA accepts Schering's corifollitropin alfa submission for review

FDA's Cardio Renal Advisory Committee to review prasugrel

King provides update on Embeda NDA review

Pfizer exercises commercial license agreement for novel vaccines with Cytos

FDA approves once-daily Ryzolt for moderate to moderately severe pain

Galapagos selects preclinical candidate, G-100192, for cachexia program

Alnylam files IND application with FDA to initiate phase I human clinical trial of ALN-VSP

Roche purchases shares in tender offer for Memory Pharmaceuticals

Death of Chinese minor not related to Sinovac's hepatitis A vaccine Healive

Valeant Pharmaceuticals International completes acquisition of Dow Pharmaceutical Sciences

Lodotra recommended for European regulatory approval

MedImmune submits MAA in European Union for intranasal influenza

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...